Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern.
PML after natalizumab discontinuation: Few and true?
Unwrapping Neurotrophic Cytokines and Histone Modification.
High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.
Demyelinating CNS Lesions in a Teenager.
Automatic iterative segmentation of multiple sclerosis lesions using Student's t mixture models and probabilistic anatomical atlases in FLAIR images.
Sedentary behaviour in people with multiple sclerosis: Is it time to stand up against MS?
[Multiple sclerosis: a comprehensive treatment and rehabilitation].
Multiple sclerosis: Daclizumab HYP shows efficacy in patients with relapsing-remitting MS.
Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68.
Multiple Sclerosis and Experimental Allergic Encephalomyelitis.
Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions.
The potential of epigenetic therapies in neurodegenerative diseases.
Whole brain myelin mapping using T1- and T2-weighted MR imaging data.
Functional cerebral changes in multiple sclerosis patients during an autobiographical memory test.
Inhibitors of myelination: ECM changes, CSPGs and PTPs.
Serum sickness reaction with skin involvement induced by bee venom injection therapy.
Dendritic cells in brain diseases.
Demographic and clinical profile of myelopathy patients.
Oral fingolimod to treat multiple sclerosis: see your cardiologist first.
Control of Macrophage Dynamics as A Potential Therapeutic Approach for Clinical Disorders Involving Chronic Inflammation.
Expression Profile of Long Noncoding RNAs in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients.
Recommendations for observational studies of comorbidity in multiple sclerosis.
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood.
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study.

Pages